Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 10 of 10 entries
View as:

A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT02335164 Org: User:
Start: 07/31/15 End: 05/01/19 Due: 05/01/20

Recombinant H7 Hemagglutinin Influenza Vaccine Trial

Phase: N/A Priority: Normal
NCT ID: NCT03038776 Org: User:
Start: 01/31/17 End: 05/31/19 Due: 05/31/20

A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT03038802 Org: User:
Start: 09/30/24 End: 12/31/26 Due: 12/31/27

Safety and Efficacy Study of Adjuvanted Prophylactic Hepatitis B Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01951677 Org: User:
Start: 07/31/13 End: 05/31/19 Due: 05/31/20

Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT05148871 Org: User:
Start: 03/01/22 End: 10/06/24 Due: 10/06/25

Monovalent Recombinant COVID19 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT04453852 Org: User:
Start: 06/30/20 End: 04/14/21 Due: 04/14/22

A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)

Phase: N/A Priority: Normal
NCT ID: NCT05279456 Org: User:
Start: 08/15/22 End: 10/30/24 Due: 10/30/25

Booster Study of SpikoGen COVID-19 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT05542862 Org: User:
Start: 09/07/22 End: 10/30/24 Due: 10/30/25

Autologous Tumour Vaccine Trial

Phase: N/A Priority: Normal
NCT ID: NCT05807035 Org: User:
Start: 02/10/23 End: 02/10/28 Due: 02/10/29

Covid-19 and Influenza Oral Vaccine Study

Phase: N/A Priority: Normal
NCT ID: NCT06355232 Org: User:
Start: 05/01/24 End: 12/31/25 Due: 12/31/26